Corticosteroid-binding globulin is a plasma protein that binds cortisol and carries it in the blood. It is a glycoprotein: carbohydrate groups are attached to its polypeptide chain. Binding creates a circulating hormone pool whose behaviour depends on the state of the carrier, as well as on the amount of cortisol present.[ref]
In a 1990 experiment, neutrophil elastase cleaved corticosteroid-binding globulin near its C-terminus. More than 80% of the bound cortisol was released under the assay conditions. The carrier did not inhibit the enzyme; it served as a substrate. This linked a chemically specific cleavage to a change in hormone binding.[ref]
The experiment illustrates why total hormone and freely dissolved hormone are different quantities. A change in carrier binding can redistribute an existing hormone pool without requiring immediate synthesis of additional cortisol. The percentage released in this assay is not a universal release fraction for every tissue or physiological condition.
G. L. Hammond 2026-11-05
G. L. Hammond investigated how circulating binding proteins influence access to steroid hormones. A 1990 study examined corticosteroid-binding globulin, a blood plasma protein that binds cortisol, and its interaction with neutrophil elastase.[ref]
In the assay, neutrophil elastase cleaved corticosteroid-binding globulin near its terminal region and released more than 80% of its bound cortisol. The cleavage did not inhibit the enzyme. The work supplied a molecular mechanism by which a hormone-binding carrier can change local hormone availability, while the proposed physiological delivery role requires distinguishing an experimental mechanism from its magnitude in living tissue.[ref]
Figure 1.
G. L. Hammond
. Portrait linked from the BC Children's Hospital Research Institute profile, which identifies his research on steroid-binding proteins.
William Daughaday 2026-11-05
William H. Daughaday was a researcher in endocrinology whose work helped connect growth hormone to circulating growth-promoting factors, including insulin-like growth factor 1. He became the founding chief of Washington University's Metabolism Division in 1951 and later led its diabetes and endocrine research centers. The division's institutional history also credits his work on corticosteroid-binding globulin and early measurements of growth hormone and prolactin.[ref]
With W. D. Salmon Jr., Daughaday investigated why blood serum could stimulate sulfate incorporation in isolated cartilage. The resulting somatomedin hypothesis made an important conceptual separation: a hormone released by one organ can act through another circulating signal. Daughaday's 2000 retrospective describes the historical experiments behind that interpretation; later identification of insulin-like growth factor 1 gave a molecular identity to an important part of this activity.[ref]
The distinction remains useful when interpreting experiments: observing a growth hormone-dependent response in a whole animal does not show that growth hormone acts directly on the responding tissue.